Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Treehouse Biotech, also known as TreeHouse Biosciences, is a science-driven biotechnology company specializing in the extraction, purification, and formulation of hemp-derived cannabinoids. The company is a leader in the production of high-purity cannabinoid isolates and broad-spectrum distillates, utilizing advanced scientific methods and Good Manufacturing Practices (GMP). Treehouse holds a significant portfolio of intellectual property, including patented technologies for THC remediation via chromatography and the selective conversion of THC into other cannabinoids like CBN. Following its acquisition by Next Frontier Brands, the company serves as a center of scientific excellence, providing ingredients and formulation services for the global hemp-based wellness and beverage industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Treehouse.